EP 2118075 A1 20091118 - BICYCLIC HETEROCYCLES, DRUGS CONTAINING SAID COMPOUNDS, USE THEREOF, AND METHOD FOR PRODUCTION THEREOF
Title (en)
BICYCLIC HETEROCYCLES, DRUGS CONTAINING SAID COMPOUNDS, USE THEREOF, AND METHOD FOR PRODUCTION THEREOF
Title (de)
BICYCLISCHE HETEROCYCLEN, DIESE VERBINDUNGEN ENTHALTENDE ARZNEIMITTEL, DEREN VERWENDUNG UND VERFAHREN ZU IHRER HERSTELLUNG
Title (fr)
HÉTÉROCYCLES BICYCLIQUES, AGENTS PHARMACEUTIQUES CONTENANT CES COMPOSÉS, LEUR UTILISATION ET LEUR PROCÉDÉ DE PRÉPARATION
Publication
Application
Priority
- EP 2008051141 W 20080130
- EP 07101785 A 20070206
- EP 07118700 A 20071017
- EP 08708456 A 20080130
Abstract (en)
[origin: WO2008095847A1] The invention relates to bicyclic heterocycles of general formula (I), wherein R<SUP>a</SUP>, R<SUP>b</SUP> and R<SUP>c</SUP> are defined as in claim 1, to the tautomers thereof, the stereoisomers thereof, the mixtures thereof and the salts thereof, especially the physiologically acceptable salts thereof with inorganic or organic acids or bases, which have valuable pharmacological properties, especially an inhibitory effect on tyrosinkinase-mediated signal transduction. The invention also relates to the use of said compounds in the treatment of diseases, especially of tumors and of benign prostatic hyperplasia (BPH), lung diseases and respiratory tract diseases, and to the production thereof.
IPC 8 full level
C07D 239/94 (2006.01); A61K 31/517 (2006.01); A61P 35/00 (2006.01); C07D 401/12 (2006.01)
CPC (source: EP KR US)
A61K 31/517 (2013.01 - KR); A61P 1/00 (2017.12 - EP); A61P 1/04 (2017.12 - EP); A61P 1/16 (2017.12 - EP); A61P 11/00 (2017.12 - EP); A61P 11/06 (2017.12 - EP); A61P 13/08 (2017.12 - EP); A61P 17/06 (2017.12 - EP); A61P 27/16 (2017.12 - EP); A61P 29/00 (2017.12 - EP); A61P 35/00 (2017.12 - EP); A61P 35/04 (2017.12 - EP); A61P 37/02 (2017.12 - EP); A61P 43/00 (2017.12 - EP); C07D 239/94 (2013.01 - EP KR US); C07D 401/12 (2013.01 - EP KR US)
Citation (search report)
See references of WO 2008095847A1
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR
Designated extension state (EPC)
BA RS
DOCDB simple family (publication)
WO 2008095847 A1 20080814; AR 065195 A1 20090520; AU 2008212999 A1 20080814; BR PI0807234 A2 20140603; CA 2677336 A1 20080814; CL 2008000356 A1 20090327; CO 6210816 A2 20101020; EA 200901041 A1 20100226; EC SP099562 A 20090929; EP 2118075 A1 20091118; IL 199923 A0 20100415; JP 2010518045 A 20100527; JP 5377332 B2 20131225; KR 20090116782 A 20091111; MA 31171 B1 20100201; MX 2009007610 A 20090724; TN 2009000332 A1 20101231; TW 200846330 A 20081201; US 2010022505 A1 20100128; US 7998949 B2 20110816
DOCDB simple family (application)
EP 2008051141 W 20080130; AR P080100494 A 20080205; AU 2008212999 A 20080130; BR PI0807234 A 20080130; CA 2677336 A 20080130; CL 2008000356 A 20080205; CO 09081877 A 20090805; EA 200901041 A 20080130; EC SP099562 A 20090805; EP 08708456 A 20080130; IL 19992309 A 20090716; JP 2009548658 A 20080130; KR 20097018469 A 20080130; MA 32150 A 20090806; MX 2009007610 A 20080130; TN 2009000332 A 20090805; TW 97104708 A 20080205; US 52574208 A 20080130